NDC 49281-718
Flublok Quadrivalent
Influenza A Virus A/michigan/45/2015 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/singapore/infimh-16-0019/2016 (h3n2) Recombinant Hemagglutinin Antigen, Influenza B Virus B/maryland/15/2016 Recombinant Hemagglutinin Antigen, And Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen
Flublok Quadrivalent is a Intramuscular Injection in the Vaccine category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is Influenza A Virus A/michigan/45/2015 (h1n1) Recombinant Hemagglutinin Antigen; Influenza A Virus A/singapore/infimh-16-0019/2016 (h3n2) Recombinant Hemagglutinin Antigen; Influenza B Virus B/maryland/15/2016 Recombinant Hemagglutinin Antigen; Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen.
| Product ID | 49281-718_53a8b76c-77bb-4506-bb65-860b73b1af3c |
| NDC | 49281-718 |
| Product Type | Vaccine |
| Proprietary Name | Flublok Quadrivalent |
| Generic Name | Influenza A Virus A/michigan/45/2015 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/singapore/infimh-16-0019/2016 (h3n2) Recombinant Hemagglutinin Antigen, Influenza B Virus B/maryland/15/2016 Recombinant Hemagglutinin Antigen, And Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2018-06-29 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125285 |
| Labeler Name | Sanofi Pasteur Inc. |
| Substance Name | INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN |
| Active Ingredient Strength | 45 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| NDC Exclude Flag | N |